US4984574A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Noninvasive fetal oxygen monitor using NMR
Assignee: Individual
•
Filing: 1988-11-23
•
Granted: 1991-01-15
•
Expires: 2008-11-23
Abstract
Abstract A non-invasive method for continuously monitoring blood and tissue oxygenation of a human fetus prior to and during labor and delivery. A specialized NMR spectrometer, whose static-field magnet is large enough to admit the abdomen of a pregnant woman at term, obtains resonance signals from a spatial region within the mother that includes the fetus. Resonance signals originating from the oxygen-transport protein hemoglobin are continuously obtained and analyzed. Signals originating from the special form of hemoglobin found in the fetal circulation are distinguished from those from the adult form of hemoglobin found in the maternal circulation. By continuously comparing the amplitudes of specific fetal hemoglobin resonances that are characteristically shifted upon oxygen binding with the amplitudes of other fetal hemoglobin resonances that are not so shifted, the method yields a continuous measurement of fetal blood and tissue oxygenation. Further analysis of the resonance signals yields indications of fetal blood acidity, heartbeat and respiration and corresponding indications of maternal condition. The method is also applicable to newborn infants and to certain mammals other than humans.
Inventors
- 👤 Seth Goldberg
- 👤 Jonothan L. Logan
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 22:13
CPC Classifications
G; G01; G01R; G01R33/00; G01R33/20; G01R33/44; G01R33/48; G01R33/483; G01R33/485; A; A61; A61B; A61B5/00; A61B5/145; A61B5/14539; A61B5/14542; A61B5/1468; A61B5/1482; A61B5/43; A61B5/4306; A61B5/4343; A61B5/4362; G01R33/46; G01R33/465
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
134 words
A method of determining the oxygenation level of an animal which comprises: (a) obtaining an NMR spectrum originating in the hemoglobin molecules of the animal; (b) determining the amplitude of a nuclear magnetic resonance (NMR) signal from said NMR spectrum which originates in a nucleus within the hemoglobin molecules of the animal and which has a chemical shift characteristic of the hemoglobin oxygenation level; (c) determining the amplitude of an NMR signal from said NMR spectrum which originates in a nucleus within the hemoglobin molecules of the animal and which has a chemical shift independent of the hemoglobin molecule oxygenation level; and (d) determining a ratio of the first determined amplitude from step (b), to the second determined amplitude from step (c), the ratio constituting a measure of the oxygenation level of the animal.
Claim 2
Independent Claim
134 words
A method of determining the oxygenation level of an animal which comprises: (a) obtaining an NMR spectrum originating in the hemoglobin molecules of the animal; (b) determining the amplitude of a nuclear magnetic resonance (NMR) signal from said NMR spectrum which originates in a nucleus within the hemoglobin molecules of the animal and which has a chemical shift characteristic of the hemoglobin oxygenation level; (c) determining the amplitude of an NMR signal from said NMR spectrum which originates in a nucleus within the hemoglobin molecules of the animal and which has a chemical shift independent of the hemoglobin molecule oxygenation level; and (d) determining a ratio of the first determined amplitude from step (b), to the second determined amplitude from step (c), the ratio constituting a measure of the oxygenation level of the animal.
Claim 3
Dependent Claim
16 words
The method according to claim 1, wherein the animal is a living fetus within its mother.
Claim 4
Independent Claim
195 words
A method of determining the oxygenation level of a living fetus within its mother which comprises: (a) obtaining an NMR spectrum originating in the total hemoglobin of the mother and fetus; (b) determining the amplitude of a first fetal nuclear magnetic resonance (NMR) signal from said NMR spectrum which originates in a nucleus within the fetal hemoglobin (HbF) molecules of the fetus, which is characteristic of fetal hemoglobin (HbF) molecules and distinguishable from nuclear magnetic resonance signals originating within the adult-type hemoglobin (HbA) molecules of the mother, and which has a chemical shift characteristic of the fetal hemoglobin oxygenation level; (c) determining the amplitude of a second fetal NMR signal which originates in a nucleus within the fetal hemoglobin (HbF) molecules of the fetus, which is characteristic of fetal hemoglobin (HbF) molecules and distinguishable from nuclear magnetic resonance signals originating within the adult-type hemoglobin (HbA) molecules of the mother, and has a characteristic chemical shift independent of the fetal hemoglobin oxygenation level; and (d) determining a ratio of the first determined amplitude from step (b), to the second determined amplitude from step (c), the ratio constituting a measure of the oxygenation level of the fetus.
Claim 5
Independent Claim
195 words
A method of determining the oxygenation level of a living fetus within its mother which comprises: (a) obtaining an NMR spectrum originating in the total hemoglobin of the mother and fetus; (b) determining the amplitude of a first fetal nuclear magnetic resonance (NMR) signal from said NMR spectrum which originates in a nucleus within the fetal hemoglobin (HbF) molecules of the fetus, which is characteristic of fetal hemoglobin (HbF) molecules and distinguishable from nuclear magnetic resonance signals originating within the adult-type hemoglobin (HbA) molecules of the mother, and which has a chemical shift characteristic of the fetal hemoglobin oxygenation level; (c) determining the amplitude of a second fetal NMR signal which originates in a nucleus within the fetal hemoglobin (HbF) molecules of the fetus, which is characteristic of fetal hemoglobin (HbF) molecules and distinguishable from nuclear magnetic resonance signals originating within the adult-type hemoglobin (HbA) molecules of the mother, and has a characteristic chemical shift independent of the fetal hemoglobin oxygenation level; and (d) determining a ratio of the first determined amplitude from step (b), to the second determined amplitude from step (c), the ratio constituting a measure of the oxygenation level of the fetus.
Claim 6
Dependent Claim
51 words
The method according to claim 3, wherein NMR analysis is performed on a volume of space approximating the region of space occupied by the fetus in the mother through the use of NMR transmitting and receiving means designed to transmit and receive NMR signals to and from the volume of space.
Claim 7
Dependent Claim
42 words
The method according to claim 3, wherein further analysis of the NMR signals is performed in order to measure pH-dependent shifts in hemoglobin NMR signals so as to obtain an indication of changes in blood acidity of the fetus or the mother.
Claim 8
Dependent Claim
31 words
The method according to claim 5, wherein the pH-dependent shifts in hemoglobin NMR signals are the ring-current-shifted proton resonances found between approximately -5.0 and -7.0 ppm upfield from HDO in HbCO.
Claim 9
Dependent Claim
60 words
The method according to claim 5, wherein further analysis of the NMR signals is performed in order to detect small periodic variations in blood oxygenation that result from rhythmic activity of the heart and lungs of the fetus or the mother, so as to obtain an indication of fetal heartbeat, fetal respiration, maternal heartbeat, maternal respiration or any combination thereof.
Claim 10
Dependent Claim
48 words
The method according to claim 5, wherein NMR analysis is performed on a volume of space approximating the region of space occupied by the fetus in the mother through the use of shaped magnets designed to produce a constant substantially uniform magnetic field throughout the volume of space.
References Cited (Backward Citations)
US4240439A
Cited
US4411270A
Cited
US4543959A
Cited
US4477777A
Cited
US4586511A
Cited
US4721914A
Cited
US4682112A
Cited
US4564017A
Cited
US4694837A
Cited
US4734039A
Cited
US4770182A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-01-14 | 1994-07-16 | 1995-01-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-01-14 | 1998-07-16 | 1999-01-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-01-14 | 2002-07-16 | 2003-01-15 | $7700.00 | Window Closed / Lapsed |